Florida is one of the most accessible states in the country for GLP-1 prescribing via telehealth. The 2023 telehealth rule updates from the Florida Board of Medicine allow practitioners to establish a patient relationship through synchronous video or phone evaluation without requiring an in-person visit. Florida also has full practice authority for nurse practitioners and a high density of state-licensed compounding pharmacies. The result is that most Florida residents have multiple realistic paths to semaglutide.
This guide covers the legal framework, what coverage looks like, what cash-pay actually costs, and the climate and logistics considerations specific to Florida.
The legal framework
Florida's telehealth statute (Section 456.47, Florida Statutes) and the Florida Board of Medicine rule 64B8-9.0141 govern remote prescribing. The relevant points for GLP-1 patients:
- No in-person visit required. A licensed Florida practitioner can establish a practitioner-patient relationship via synchronous audiovisual or audio-only telehealth. A documented evaluation is required; a brief intake form alone is not sufficient.
- Florida licensure required. The prescriber must hold an active Florida medical license, osteopathic license, or advanced practice registered nurse license (with prescriptive authority).
- Full NP practice authority. Florida allows nurse practitioners to prescribe independently without physician supervision after meeting the autonomous practice requirements, broadening the pool of available prescribers.
- Synchronous evaluation. The initial evaluation must occur in real time via video or audio. Asynchronous-only intake (text-based or form-only) does not establish a valid prescribing relationship under Florida rules.
- Standard of care. The telehealth visit must meet the same standard of care as an in-person visit. The practitioner must take an appropriate history, review medications, address contraindications, and arrange follow-up.
What Florida insurance covers
Florida Medicaid does not cover GLP-1 medications for weight loss. Florida is one of the majority of states that has not added obesity as a covered indication for the GLP-1 class. Coverage is available for Type 2 diabetes through the standard preferred drug list with prior authorization requirements.
Commercial coverage in Florida varies widely. The major Florida insurers (Florida Blue, Aetna, UnitedHealthcare, Humana, Cigna) generally cover Wegovy and Zepbound for adults meeting BMI criteria, with prior authorization and often a step therapy requirement (typically requiring documented attempt at lifestyle modification or another weight-loss medication first). Self-insured employer plans set their own rules; some cover GLP-1s liberally while others exclude them entirely.
Medicare in Florida covers Wegovy for the cardiovascular indication (MACE risk reduction in adults with overweight or obesity and established CVD) following the FDA's 2024 approval and CMS's 2024 coverage determination. Coverage for weight loss alone is not available under Medicare Part D.
Cash-pay options ranked
Telehealth compounded
The dominant path for Florida cash-pay patients. Telehealth providers operating in Florida partner with state-licensed 503A compounding pharmacies to prepare semaglutide for individual patients with a prescription. Monthly pricing typically runs $179 to $349 depending on dose, provider, and whether the patient is on a monthly or multi-month plan. The compounded product contains the same active pharmaceutical ingredient as the branded reference product when prepared by a reputable pharmacy meeting USP standards.
What to verify before signing up: that the prescribing practitioner is Florida-licensed; that the dispensing pharmacy is either Florida-licensed or holds a Florida nonresident pharmacy permit; that synchronous video or phone evaluation is part of the intake; that the program includes follow-up visits and dose adjustments without additional fees.
Manufacturer direct
Novo Nordisk's NovoCare Pharmacy offers Wegovy at $499 per month for cash-pay patients, with shipping to Florida addresses. Eli Lilly's LillyDirect offers Zepbound vials starting at $349 per month for lower doses and $449 per month for higher doses. Both programs require online enrollment through the manufacturer portal. The medications are FDA-approved branded products.
Retail pharmacy without insurance
Wegovy at retail without coverage runs approximately $1,349 per month. Zepbound runs $1,059 to $1,250. These prices are largely theoretical in 2026; few patients pay the unblunted retail cash price because the manufacturer direct programs are cheaper, and most patients with no insurance gravitate toward compounded or direct options.
HSA and FSA reimbursement
Florida residents with HSA or FSA accounts can typically reimburse GLP-1 prescriptions when accompanied by a Letter of Medical Necessity from the treating practitioner. This applies to both branded and compounded products. The effective discount depends on the patient's marginal tax rate but generally lands in the 22 to 32 percent range.
Climate and logistics considerations
Florida's heat and humidity matter for any home-shipped, refrigerated medication. Compounded semaglutide and branded Wegovy both require refrigeration at 36 to 46 degrees Fahrenheit. Two practical implications:
Shipping windows
Most home-shipped GLP-1 programs use cold-chain packaging rated for 48 to 72 hours in transit. During Florida summer peak (June through September), packages left on a porch in direct sun can exceed the safe temperature window in well under 24 hours. Reputable programs ship with signature required and time the delivery to coincide with patient availability. Patients should confirm shipping protocols and avoid scheduling deliveries when they'll be away from home all day.
Hurricane season
Florida hurricane season runs June through November. During named storm preparation and recovery, shipping delays of 3 to 7 days are common in affected areas. Patients with a known weather event approaching should request early refills when their program allows. Refrigerator power loss during extended outages is a separate concern; medications kept above the labeled temperature range for more than 24 hours generally need to be replaced.
Snowbird patients
A meaningful share of Florida residents spend part of the year in another state. The prescribing rules of the patient's physical location (not their official residence) generally apply. A patient who spends six months in Florida and six months in Michigan needs a prescriber licensed in whichever state they're physically in at the time of the visit. Many Florida-focused programs accommodate this by having providers cross-licensed in common snowbird destinations, but patients should confirm before traveling.
Geographic considerations within Florida
The major metropolitan areas (Miami-Fort Lauderdale, Tampa-St. Petersburg, Orlando, Jacksonville) have the highest density of in-person GLP-1 providers and state-licensed sterile compounding pharmacies. Telehealth coverage is statewide and not affected by the patient's specific Florida zip code. Patients in less dense areas (the Panhandle, the southwest coast outside Naples, the rural central counties) have identical telehealth access to those in Miami; the only practical difference is FedEx and UPS service reliability during weather events.
Frequently asked questions
Can a Florida resident use a telehealth provider based in another state? The patient can interact with a company headquartered anywhere, but the actual prescribing clinician must be Florida-licensed. Reputable cross-state telehealth providers will assign Florida residents to Florida-licensed practitioners. Verify this before paying.
Does Florida require an in-person visit for GLP-1 prescribing? No. Florida allows the practitioner-patient relationship to be established entirely through synchronous telehealth (video or phone). The visit must meet the standard of care, including history-taking, contraindication review, and follow-up planning.
Is compounded semaglutide legal in Florida in 2026? Yes, when prepared by a state-licensed 503A pharmacy for an individual patient with a valid prescription from a Florida-licensed practitioner. The federal shortage that previously authorized broader compounding ended in February 2025; 503A patient-specific compounding remains legal under federal law with appropriate clinical justification (significant difference from the commercial product, or true medical necessity for the individual patient).
Will Florida Medicaid ever cover GLP-1s for weight loss? No current policy or budget proposal would add obesity as a covered indication under Florida Medicaid. Patients on Florida Medicaid with a Type 2 diabetes diagnosis can access semaglutide (Ozempic, Rybelsus) for glycemic control through the standard prior authorization process.
What's the safest way to verify a pharmacy is properly licensed? The Florida Department of Business and Professional Regulation publishes a licensee search for pharmacies. The pharmacy's name, license number, and license status are public records. For out-of-state pharmacies, the Florida Board of Pharmacy verifies nonresident pharmacy permit status.
The Bottom Line
Florida's telehealth framework, full NP authority, and pharmacy density make it one of the most accessible states for GLP-1 prescribing. The realistic cash-pay range runs from $179 per month (compounded multi-month plan) to $499 per month (NovoCare direct Wegovy). Florida Medicaid does not cover weight loss; commercial coverage varies. Patients should verify Florida licensure of both the prescriber and the dispensing pharmacy, confirm synchronous evaluation as part of the intake, and plan shipping logistics around summer heat and hurricane season.
CLYR Health serves Florida residents with Florida-licensed practitioners, 503A pharmacy fulfillment, and flat-rate pricing across all doses. Start your assessment at /intake.html.